FutureLife has acquired 80% of the capital of assisted reproduction private clinic Fecundación In Vitro Valencia (FIV Valencia). The remaining 20% of the private assisted reproduction group remains in the hands of the founding partner and medical director of the Valencian clinic, gynaecologist Miguel Dolz Arroyo. The amount of the transaction has not been made public.
FutureLife is a European leader in reproductive medicine and women’s care. It is one largest and fastest growing providers of IVF and related genetics services, with over 45 clinics in 10 countries performing more than 45,000 IVF cycles annually in addition to offering IVF add-on and laboratory services as well as a series of biological and surgical treatments. FutureLife is co-owned by CVC Capital and Hartenberg Holding.
The Group’s focus is to provide the highest quality and broadest range of fertility treatments to all patients, whilst complementing this with synergistic genetics, biological treatments and surgeries.
Cuatrecasas advised FutureLife with a team led by Barcelona office Corporate/M&A partner Alejandro Payá.
